Accelerated Ventures invests £3.5m in Biosignatures
London-based Accelerated Ventures has invested £3.5m in Newcastle-headquartered biotechnology startup Biosignatures.
More on Expansion
Atlantic Bridge leads $10m series-A for Siren
DVI Equity Partners, Frontline Ventures and Enterprise Ireland also take part
AO Proptech leads €29m series-B for Plentific
Newcomer Target Global and existing investor Round Hill Ventures also take part in the round
Cardlay secures €9m funding round
Company also agreed to partner up with Eurocard, the largest card issuer in Scandinavia
Lakestar, Dawn Capital co-lead $37m series-B for Eigen
Existing investors Temasek and Goldman Sachs Growth Equity also participate in the funding round
Latest News
Atlantic Bridge leads $10m series-A for Siren
DVI Equity Partners, Frontline Ventures and Enterprise Ireland also take part
AO Proptech leads €29m series-B for Plentific
Newcomer Target Global and existing investor Round Hill Ventures also take part in the round
CM-CIC backs Formes & Sculptures MBO
GP invests €7.3m in the France-based point-of-sale merchandising equipment provider
Azimut launches platform to invest in US-based GPs
Azimut appoints Jeffry Brown as CEO of AACP; Brown previously worked at Dyal Capital Partners